Loading...

NEULANDLAB Neuland Laboratories Ltd US FDA Inspection Announcement

Nlnd

NLND

Neuland Laboratories Ltd

(NEULANDLAB)

2024 Announcement

Analyst Meeting Cancellation

Analyst / Investor Meet

Analyst / Investor Meeting

R&D Center Relocation

Share Transfer Window

SEBI Circular Update

Regulatory Disclosure

Financial Results Published

Earnings Call Audio

Investor Presentation

Financial Results Q2

Financial Results

Financial Results Update

Earnings Call Announcement

Share Transfer Update

Board Meeting Notice

Share Transfer Update

Share Transfer Notice

Postal Ballot Notice

Compliance Certificate

Management Change

Management Changes

Share Transfer Window

Newspaper Publication

Postal Ballot Correction

Investor Meeting

Transfer Request Update

Transfer Request Notice

Dividend Campaign

Commercial Production Launched

Postal Ballot Notice

Transfer Requests Update

Investor Meeting

Share Transfer Update

Investor Meeting

Earnings Call Transcript

Financial Results Released

Earnings Call Recording

Director Appointment Correc...

Director Re-appointment

Investor Presentation

Q1 FY26 Results

Share Transfer Window

AGM Addendum Notice

Earnings Call Announcement

Volume Clarification

Compliance Certificate

AGM Notice Publication

FDA Inspection Update

Credit Rating Reaffirmed

Investor Meeting

SEBI Warning Letter

Annual General Meeting

Investor Meeting

Compliance Certificate

Investor Meeting Scheduled

Earnings Call Transcript

Annual Compliance Report

Financial Results Published

Earnings Call Recording

Appointment of Auditors

Management Change

Investor Presentation

Financial Results Q4FY25

Director Retirement

Earnings Call Scheduled

FDA Inspection Update

Compliance Certificate

Investor Meeting Scheduled

Credit Rating Affirmed

Management Change

Analyst Meet Scheduled

Q3 Earnings Report

Earnings Call Recording

Financial Results Published

Investor Presentation

Financial Results Q3

Earnings Call Intimation

Management Change

Capacity Expansion

SEBI Compliance Certificate

Insider Trading Violation

Property Transfer Update

Analyst Meeting

Investor Meeting

Investor Meetings

Property Transfer

Earnings Call Transcript

Investor Meeting

Financial Results

Earnings Call Recording

Q2FY25 Earnings

Investor Presentation

Q2 FY 2025 Earnings

Share Certificate Loss

Export Data Clarification

Regulation Compliance

Litigation Update

Investor Meeting Scheduled

Regulatory Penalty

Tax Penalty Imposed

Financial Results Publication

Investor Presentation

Financial Results

Financial Results and Capac...

Earnings Announcement

Newspaper Advertisement

Certificate Submission

Property Transfer Update

General Meeting Announcement

Analyst Meeting

Analyst Meetings

Analyst/Investor Meet

Meetings Schedule

Analyst/Investor Meetings

Annual Secretarial Compliance

Penalty Imposed

Investor Presentation

Financial Results Publication

Investor Presentation

Financial Results Announcement

Re-appointment Of Statutory...

Directorate Change

Fined by Tax Department

Earnings Release & Call

Certificate Submission

Compliance Certificate Filing

Certificate Submission

Directorate Change

Credit Rating Upgrade

FDA Inspection Outcome

Meeting Participation

Change in Management

Meeting Intimation

Earnings Call Transcript

Newspaper Publication

Audio Recording

Credit Rating Upgrade

Investor Presentation

Financial Results Announcement

Earnings Call Notice

Acquisition of Land Parcel

Certificate Submission

Changes in Management

ESG Score Announcement

Investor Meetings

Appointment of CSO

Approval of Capital Expendi...

Newspaper Publication

Financial Results Announcement

Investor Presentation

Management Change

Investor Meeting

Results Release and Earning...

Certificate Submission

Resignation of Director

Civil, Regulatory

Investor Meetings

Financial Statements

Financial Statements

Financial Statements, Earni...

Management Changes

Earnings Releases

Financial Statements

Financial Statements, Earni...

Appointment of Directors

Investor Meetings

Participation in investor c...

Divestment of assets

Institutional Investor Meeting

Minor Observations

Annual Compliance

Transcript release

Financial Statements Public...

Submission of Financial Res...

Management Appointments

Financial Results Release

Earnings Call Notice

External Links:

Data:

US FDA inspection at Neuland Laboratories Ltd Unit 1 manufacturing facility at Bonthapally, Hyderabad successfully completed with no observations under Form 483

AI Assistant

Neuland Laboratories Ltd

2024

Announcement

Find Answers

Ask about any part of the document to get insights, explanations, or key details.